PHARMACEUTICALLY ACTIVE MORPHOLINOL

PHARMACEUTICALLY ACTIVE MORPHOLINOL

Otkriven je spoj (+)-(2S,3S)-2-(3-klorfenil)-3,5,5-trimetil-2-morfolinol i njegove farmaceutski prihvatljive soli i solvati, farmaceutski pripravci koji ih sadrže; također je otkriven postupak za liječenje depresije, hiperaktivnog poremećaja nedostatka pažnje (ADHD), pretilosti, migrene, boli, seksu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PHILLIP FREDERICK MORGAN, DAVID LEE MUSSO, JOHN JOSEPH PARTRIDGE
Format: Patent
Sprache:hrv ; eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Otkriven je spoj (+)-(2S,3S)-2-(3-klorfenil)-3,5,5-trimetil-2-morfolinol i njegove farmaceutski prihvatljive soli i solvati, farmaceutski pripravci koji ih sadrže; također je otkriven postupak za liječenje depresije, hiperaktivnog poremećaja nedostatka pažnje (ADHD), pretilosti, migrene, boli, seksualne disfunkcije, Parkinsonove bolesti, Alzheimerove bolesti, ovisnosti o kokainu ili o proizvodima koji sadrže nikotin (naročito duhan) koji upotrebljava taj spoj, soli, solvate ili pripravke. Disclosed is the compound (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol and pharmaceutically acceptable salts and solvates thereof, pharmaceutical compositions comprising them; also disclosed is a method of treating depression, attention deficit hyperactivity disorder (ADHD), obesity, migraine, pain, Parkinson's disease, Alzheimer's disease, or addiction to cocaine or nicotine-containing (especially tobacco) products using such compound, salts, solvates or compositions.